Northwest Biotherapeutics (NWBO) Prepaid Assets (2010 - 2026)

Northwest Biotherapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $4.4 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 131.57% year-over-year to $4.4 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 131.57% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 14.79% from the prior year.
• Prepaid Assets rose to $4.4 million in Q1 2026 per NWBO's latest filing, from $2.2 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $4.4 million in Q1 2026 and bottomed at $1.7 million in Q3 2023.
• The 5-year median for Prepaid Assets is $2.3 million (2022), against an average of $2.4 million.
• Across the five-year window, Prepaid Assets sank 59.89% in 2022 and soared 131.57% in 2026, its largest moves.
• Year by year, Prepaid Assets stood at $2.5 million in 2022, then decreased by 18.74% to $2.0 million in 2023, then slipped by 5.6% to $1.9 million in 2024, then climbed by 14.79% to $2.2 million in 2025, then jumped by 103.88% to $4.4 million in 2026.
• Per Business Quant, the three latest NWBO Prepaid Assets figures stand at $4.4 million (Q1 2026), $2.2 million (Q4 2025), and $2.3 million (Q3 2025).